Singular Genomics Systems Inc
NASDAQ:OMIC
Intrinsic Value
Singular Genomics Systems, Inc. engages in the development and commercialization of proprietary sequencing solutions. [ Read More ]
The intrinsic value of one OMIC stock under the Base Case scenario is 1.695 USD. Compared to the current market price of 0.395 USD, Singular Genomics Systems Inc is Undervalued by 77%.
Valuation Backtest
Singular Genomics Systems Inc
Run backtest to discover the historical profit from buying and selling OMIC stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Singular Genomics Systems Inc
| Current Assets | 192.2m |
| Cash & Short-Term Investments | 175.4m |
| Receivables | 565k |
| Other Current Assets | 16.3m |
| Non-Current Assets | 73.2m |
| PP&E | 71.5m |
| Other Non-Current Assets | 1.8m |
| Current Liabilities | 18.3m |
| Accounts Payable | 2.6m |
| Accrued Liabilities | 13.8m |
| Other Current Liabilities | 1.9m |
| Non-Current Liabilities | 68.2m |
| Long-Term Debt | 8.9m |
| Other Non-Current Liabilities | 59.3m |
Earnings Waterfall
Singular Genomics Systems Inc
|
Revenue
|
2.9m
USD
|
|
Cost of Revenue
|
-3.5m
USD
|
|
Gross Profit
|
-558k
USD
|
|
Operating Expenses
|
-100.3m
USD
|
|
Operating Income
|
-100.9m
USD
|
|
Other Expenses
|
6.1m
USD
|
|
Net Income
|
-94.8m
USD
|
Free Cash Flow Analysis
Singular Genomics Systems Inc
What is Free Cash Flow?
OMIC Profitability Score
Profitability Due Diligence
Singular Genomics Systems Inc's profitability score is 37/100. The higher the profitability score, the more profitable the company is.
Score
Singular Genomics Systems Inc's profitability score is 37/100. The higher the profitability score, the more profitable the company is.
OMIC Solvency Score
Solvency Due Diligence
Singular Genomics Systems Inc's solvency score is 53/100. The higher the solvency score, the more solvent the company is.
Score
Singular Genomics Systems Inc's solvency score is 53/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
OMIC Price Targets Summary
Singular Genomics Systems Inc
According to Wall Street analysts, the average 1-year price target for OMIC is 0.867 USD with a low forecast of 0.859 USD and a high forecast of 0.893 USD.
Ownership
OMIC Insider Trading
Buy and sell transactions by insiders
| Period | Sold | Bought | Net |
|---|---|---|---|
| 3 Months |
|
|
|
| 6 Months |
|
|
|
| 9 Months |
|
|
|
| 12 Months |
|
|
|
Shareholder Return
OMIC Price
Singular Genomics Systems Inc
| Average Annual Return | -68.02% |
| Standard Deviation of Annual Returns | 21.25% |
| Max Drawdown | -99% |
| Market Capitalization | 29.2m USD |
| Shares Outstanding | 73 928 600 |
| Percentage of Shares Shorted | 1.22% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Singular Genomics Systems, Inc. engages in the development and commercialization of proprietary sequencing solutions. The company is headquartered in La Jolla, California and currently employs 221 full-time employees. The company went IPO on 2021-05-27. The firm has developed an NGS technology or sequencing engine. The company is developing two integrated solutions that are built to target specific applications. The firm's first integrated solution is targeted at the NGS market and comprises an instrument and an associated menu of consumable kits, which is collectively referred as G4 Integrated Solution. The G4 Instrument is a sequencer designed to produce accurate genetic sequencing results. Its second integrated solution in development comprises an instrument and an associated menu of consumable kits, which is collectively referred as PX Integrated Solution. The PX Integrated Solution combines single cell analysis, spatial analysis, genomics and proteomics in one integrated instrument providing a multiomics solution.
Contact
IPO
Employees
Officers
The intrinsic value of one OMIC stock under the Base Case scenario is 1.695 USD.
Compared to the current market price of 0.395 USD, Singular Genomics Systems Inc is Undervalued by 77%.
You don't have any saved screeners yet
